Kolexia
Luque Paz Damien Pharmacien
Luque Paz Damien
Pharmacien
Hôpital Larrey Angers
Angers, France
65 Activités
97 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndromes myéloprolifératifs Thrombocytémie essentielle Thrombocytose Myélofibrose primitive Polyglobulie primitive essentielle Polyglobulie Leucémies Leucémie aigüe myéloïde Leucémie myéloïde

Collaborateurs

Voir plus
Ugo Valerie
Ugo Valerie
Hôpital Larrey Angers, Angers, France
Ianotto Jean-Christophe
Ianotto Jean-Christophe
Hôpital Morvan, Brest, France
Orvain Corentin
Orvain Corentin
Hôpital Larrey Angers, Angers, France
Lippert Eric
Lippert Eric
Hôpital Cavale Blanche, Brest, France

Industries

Voir plus
LFB
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Blood smear invaders: About a fatal case of bacteremia.
International journal of laboratory hematology   26 février 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
Blood advances   11 janvier 2024
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia   27 décembre 2023
BioScoreSMP: Pilot Study for the Development of a Non-invasive Diagnostic Score to Differentiate Between Essential Thrombocythemia, Premyelofibrosis and Myelofibrosis
Essai Clinique (CHU Angers)   21 septembre 2023
Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.
HemaSphere   24 août 2023
Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms.
HemaSphere   03 mai 2023
Genetic basis and molecular profiling in myeloproliferative neoplasms.
Blood   24 avril 2023
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores.
American journal of hematology   05 avril 2023
Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group
Annual Meeting Abstracts 2022   15 novembre 2022